Gilead to buy cancer therapy developer Arcellx for up to $7.8 billion
Gilead Sciences will pay as much as $7.8 billion to acquire partner Arcellx in its largest deal since 2020, the biopharma company said on Monday.
Novo Nordisk sinks 15% after weight loss drug fails to match Eli Lilly’s in trial
Novo Nordisk stock fell 15% Monday after it said its next-generation weight loss drug didn’t meet its primary target.
EU postpones vote on U.S. trade deal after Trump’s latest tariff threat
European officials have reacted with disbelief to President Donald Trump’s latest tariff policy, warning that trade deals could be at risk.
Treasury yields fall as investors weigh new Trump tariffs
U.S. Treasury yields were little changed to start the week as investors weighed President Donald Trump’s latest tariffs.
Sam Altman defends AI resource usage: Water concerns ‘fake,’ and ‘humans use energy too’
OpenAI CEO Sam Altman defended the resource use of AI on Friday, arguing that water concerns were “fake” and comparing it to human energy use.
Some U.S. allies see higher duties under new tariffs, rivals see relief, trade body says
U.S. allies and partners like the U.K. and the European Union facing higher tariffs but countries like Brazil, China and India get a reprieve.
Dow drops 800 points as AI disruption fears and tariff woes weigh on markets: Live updates
The major averages were under pressure as worries over AI disruption and Trump’s tariffs pulled stocks lower.
CNBC Daily Open: New Trump tariffs are up after U.S. Supreme Court strikes some down
The U.S. Supreme Court on Friday struck down much of President Donald Trump’s “reciprocal” tariffs. But Trump didn’t take their decision lying down.
‘Sit still and do nothing’: Trump’s latest tariff salvos leave markets unfazed
Asia stocks were mostly higher, safe-haven assets stayed firm, with yield on the 10-year U.S. Treasury little changed, while gold inched about 1% higher.
European stocks end lower as markets react to new Trump tariffs
European stocks closed lower on Monday as global markets reacted to U.S. President Donald Trump’s latest global tariffs policy.
